Open-label trial of ramelteon for sleep disorder with diabetes mellitus

Open-label trial of ramelteon for sleep disorder with diabetes mellitus - Ramelteon trial for sleep disorder with diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006683

Enrollment

Registered

2011-11-07

Start date

2011-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus with sleep disorder

Interventions

ramelteon

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type II diabetes mellitus with sleep disorder

Exclusion criteria

Exclusion criteria: On fluvoxamine Intractable diabetes mellitus Pregnancy Ramelteon sensitivity Severe brain disease Severe somatic disease

Design outcomes

Primary

Measure	Time frame
Quality of sleep Values for DM	—

Secondary

Measure	Time frame
Sleep diary Change of DM medication	—

Countries

Japan

Contacts

Public ContactMizue Hobo

Tokyo Medical and Dental University Graduate School Department of Sleep Madulatory Medicine

hobo-psy@umin.ac.jp03-3813-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026